1. Regorafenib inhibits growth, survival and angiogenesis in nasopharyngeal carcinoma and is synergistic with Mcl-1 inhibitor
   Jiangping Li et al, 2023, Journal of Pharmacy and Pharmacology CrossRef
2. The Role of Epstein-Barr Virus in Modulating Key Tumor Suppressor Genes in Associated Malignancies: Epigenetics, Transcriptional, and Post-Translational Modifications
   Adelaide Ohui Fierti et al, 2022, Biomolecules CrossRef
3. Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma
   Yock Ping Chow et al, 2017, Scientific Reports CrossRef
4. Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe
   George Fountzilas et al, 2018, International Journal of Cancer CrossRef
5. Diagnostic and Prognostic Indications of Nasopharyngeal Carcinoma
   Engku Nur Syafirah E. A. R. et al, 2020, Diagnostics CrossRef
6. Nasopharyngeal Carcinoma
   Maria Li Lung et al, 2019, Nasopharyngeal Carcinoma CrossRef
7. Preclinical evaluation of the dual mTORC1/2 inhibitor sapanisertib in combination with cisplatin in nasopharyngeal carcinoma
   Jianbin Zhang et al, 2022, European Journal of Pharmacology CrossRef
8. MassARRAY determination of somatic oncogenic mutations in solid tumors: Moving forward to personalized medicine
   Tania Fleitas et al, 2016, Cancer Treatment Reviews CrossRef
9. Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma
   Jian-Wei Zhang et al, 2015, Chinese Journal of Cancer CrossRef
10. HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma
    Xianyue Ren et al, 2017, Nature Communications CrossRef
11. EGFR Mutation in Nasopharyngeal Carcinoma
    Evren Uzun et al, 2022, Journal of Molecular Pathology CrossRef
12. Establishment and Characterization of an Epstein-Barr Virus–positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma
    Annie Wai Yeeng Chai et al, 2024, Cancer Research Communications CrossRef
13. The molecular march of primary and recurrent nasopharyngeal carcinoma
    Nicholas J. Campion et al, 2021, Oncogene CrossRef
14. Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma
    Satoru Kondo et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
15. Nasopharyngeal Cancer: Molecular Landscape
    Jeff P. Bruce et al, 2015, Journal of Clinical Oncology CrossRef